Amarillo Biosciences

(AMAR)

By |

Profile

Amarillo Biosciences Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low dose oral form.

Contact Information

Website: www.amarbio.com
Email: jcummins@amarbio.com
Main Phone: +1 806 376-1741
Address: 4134 Business Park Drive
State: TX
City / Town: Amarillo
Country: USA
Postal Code: 79110-4225

Issuer Information

Exchange: OTO
CEO: Stephen T. Chen
Employees: 4
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Amarillo Biosciences Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low dose oral form.

Contact Information

Website: www.amarbio.com
Email: jcummins@amarbio.com
Main Phone: +1 806 376-1741
Address: 4134 Business Park Drive
State: TX
City / Town: Amarillo
Country: USA
Postal Code: 79110-4225

Issuer Information

Exchange: OTO
CEO: Stephen T. Chen
Employees: 4
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 0.24 $ -0.0064 (-2.60%)
Last Price 0.24 Change $ -0.0064 Change % -2.60 Tick N/A
Bid 0.20 Bid Size 9,300.00 Ask 0.24 Ask Size 10,000.00
Open 0.24 High 0.24 Low 0.22 Prev Close 0.25
Last Trade Volume 11,499 52 Wk Hi 0.47 52 Wk Low 0.18
Market Cap 9.7 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 40,516,351.00 EPS (TTM) -0.04 PE Ratio N/A Exchange OTCPK